Deficiency of SCAMP5 leads to pediatric epilepsy and dysregulation of neurotransmitter release in the brain

Hum Genet. 2020 Apr;139(4):545-555. doi: 10.1007/s00439-020-02123-9. Epub 2020 Feb 4.

Abstract

Secretory carrier membrane proteins (SCAMPs) play an important role in exocytosis in animals, but the precise function of SCAMPs in human disease is unknown. In this study, we identified a homozygous mutation, SCAMP5 R91W, in a Chinese consanguineous family with pediatric epilepsy and juvenile Parkinson's disease. Scamp5 R91W mutant knock-in mice showed typical early-onset epilepsy similar to that in humans. Single-neuron electrophysiological recordings showed that the R91W mutation significantly increased the frequency of miniature excitatory postsynaptic currents (mEPSCs) at a resting state and also increased the amplitude of evoked EPSCs. The R91W mutation affected the interaction between SCAMP5 and synaptotagmin 1 and may affect the function of the SNARE complex, the machinery required for vesicular trafficking and neurotransmitter release. Our work shows that dysfunction of SCAMP5 shifted the excitation/inhibition balance of the neuronal network in the brain, and the deficiency of SCAMP5 leads to pediatric epilepsy.

MeSH terms

  • Action Potentials*
  • Animals
  • Brain* / metabolism
  • Brain* / pathology
  • Epilepsy* / genetics
  • Epilepsy* / metabolism
  • Epilepsy* / pathology
  • Gene Knock-In Techniques
  • HEK293 Cells
  • Humans
  • Membrane Proteins* / genetics
  • Membrane Proteins* / metabolism
  • Mice
  • Mice, Transgenic
  • Mutation, Missense*
  • Nerve Net* / metabolism
  • Nerve Net* / pathology
  • Neurotransmitter Agents / metabolism*
  • Synaptic Potentials*

Substances

  • Membrane Proteins
  • Neurotransmitter Agents
  • SCAMP5 protein, human